99% Purity CAS 192725-17-0 Lopinavir Pharmaceutical Lopinavir Powder Lopinavir

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Lopinavir
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Lopinavir
• Name: Lopinavir Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anti-Aids
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 192725-17-0
• Mf: C37h48n4o5
• MW: 628.814
• Density: 1.163
• Melting Point: 124-127 C
• Boiling Point: 924.1 C at 760 Mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 500 Kg/Month

Product Description

99% Purity CAS 192725-17-0 Lopinavir Pharmaceutical Lopinavir Powder Lopinavir

 

Product Description

Product Details

Product Name	Lopinavir
CAS No.	192725-17-0
MF	C37H48N4O5
MW	628.814
Appearance and shape	White powder

Lopinavir is a potent HIV protease inhibitor with Ki of 1.3 pM. Lopinavir is the phosphate salt of chloroquine, a compound with antimalarial and anti-inflammatory properties. Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum. Although the mechanism of action is not fully understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite.   Chloroquine may also interfere with the biosynthesis of nucleic acids.

Application & Function

Function of Lopinavir
Lopinavir is an antiretroviral of the protease inhibitor class.  Inhibition of HIV-1 protease prevents cleavage of the viral polyprotein precursor and results in the release of immature, noninfectious virions.  A component of combination therapy to treat HIV/AIDS.
Application of Lopinavir
Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum.  Although the mechanism of action is not fully understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite.

Specification